Skip to main content
!
Phase III+: The University is open for expanded research operations; only authorized personnel will be admitted on campus. More info here.

Rockefeller grants commercial license for the development of new HIV drugs

The novel compounds are based on so-called broadly neutralizing antibodies, molecules that make rare people's immune systems capable of fighting HIV. They could potentially yield new treatment and prevention approaches benefitting people around the world, including in developing countries.

The Tri-Institutional Therapeutics Discovery Institute renews partnerships with Takeda and Bridge Medicines

The renewal allows Rockefeller faculty to continue transforming their discoveries into new medicines.

>

Neuron-like activity detected in an unforeseen place

Scientists have identified a particular type of skin cell that looks and behaves similar to a nerve cell, prompting new questions about the body's biggest organ.

New BSL-3 lab to advance research on pathogens

Rockefeller researchers studying the tuberculosis bacterium now have access to a state-of-the-art biosafety level 3 laboratory on campus. The new facility is one of only a small handful in New York City.

Becoming a Scientist: Jasmine Nirody 

She’s the physicist whose love of locomotion became a research topic, and a career.

>

Kivanç Birsoy receives 2020 Vilcek Prize for Creative Promise

Birsoy is honored for his research examining how metabolic pathways regulate biological processes and contribute to disease.

Rockefeller joins tri-institutional Ph.D. program in computational biology

Data analysis is becoming increasingly important in all fields of science. In joining the program, Rockefeller will connect with a stream of talented students focused on computational problems.

Patient with unusually severe infection leads scientists to a rare type of immune deficiency

A rare genetic change may explain why some people die from cytomegalovirus, a stealth pathogen that is often asymptomatic.

Erich D. Jarvis speaks with high-school students about the evolution of speech and diversity in science

On a recent Saturday, over 400 teens crowded into Caspary Auditorium to hear Jarvis’s 2020 Talking science seminar, “Singing in the Brain: A Personal Science Journey.”

Small containers inside cells might offer new targets for cancer treatment

For reasons that have long been unclear, cells stop dividing when the pH rises inside tiny cellular compartments called lysosomes. Now scientists have found an explanation for this phenomenon, with potential implications for drug development.

Recent Awards and Honors

Junyue Cao

Junyue Cao wins Science & SciLifeLab Grand Prize For Young Scientists

November 19, 2020

Cao is recognized for his work using single-cell genomic methods to enable developmental mapping of entire organisms, described in an essay published in Science.
LLuciano Marraffini portrait

Luciano Marraffini awarded Max Planck-Humboldt Medal

October 14, 2020

Marraffini receives the award for his achievements studying CRISPR-Cas, a bacterial immune mechanism whose discovery led to modern gene-editing tools.
More awards and honors

Rockefeller in the News

Nature News

An innovative approach from Priya Rajasethupathy has been used to link genetics to behavior in mice. The analysis identifies a gene that underpins the role of the brain’s thalamus region in maintaining short-term memory.

NBC News

Research led by Jean-Laurent Casanova shows Covid-19 patients with life-threatening illness have antibodies that disable key immune system proteins called interferons.

Knowable Magazine

Just how sick we get from COVID-19 depends on genetic variations, including ones that sabotage immune molecules called interferons. Jean-Laurent Casanova's work aims to better understand why, which could lead to new treatments for COVID-19 and other scourges.

Seek magazine

Rockefeller’s flagship publication is interested not just in scientific results, but in the people, ideas, and conversations that ignite discovery. The latest issue takes us inside the response to the pandemic, where scientists are using every tool in the 21st century playbook to transform COVID-19 into a manageable disease. Also: Mosquito menace, The brain inside your gut, and Addiction then and now.


From this issue

 


Subscribe to Rockefeller Science News

Did you know Rockefeller has a monthly science newsletter? Subscribe now to stay on top of the latest discoveries, news updates, and science highlights from Rockefeller’s laboratories and researchers.